Helper T Cell Recognition of Respiratory Syncytial Virus in Mice Free

Abstract

Summary

In this study we aimed to define the protein and viral subtype specificities of helper T cells to respiratory syncytial virus (RSV). BALB/c mice were primed by infection with RSV, or with vaccinia viruses (VV) containing genes encoding several individual RSV proteins. Priming for T cell memory was assayed by stimulating spleen cells with different RSV isolates and measuring RSV-specific interleukin 2 (IL-2) release by T cells into supernatants using an IL-2-dependent CTLL cell line. Splenocytes from mice primed intranasally with RSV exhibited RSV-specific T cell memory, whereas those from unprimed mice did not. T cell recognition was in part specific to the strain of RSV used in priming and in part cross-reactive between RSV strains. Intraperitoneal priming with RSV fusion protein-expressing VV or nucleoprotein-expressing VV induced a stronger RSV-specific T cell response than the attachment glycoprotein-expressing VV which produced only slight T recognition. No T cell recognition of two non-structural proteins (1A and 1B) could be demonstrated.

Keyword(s): helper T cells , interleukin 2 and RSV
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-2-305
1988-02-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/2/JV0690020305.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-2-305&mimeType=html&fmt=ahah

References

  1. ANDERSON L. J., HIERHOLZER J. C, TSOU C, HENDY R. M., FERNIE B. F., STONE Y., McINTOSH K. 1985; Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. Journal of Infectious Diseases 151:626–633
    [Google Scholar]
  2. BALL L. A., YOUNG K. K. Y., ANDERSON K., COLLINS P. L., WERTZ G. 1986; Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors. Proceedings of the National Academy of Sciences, U.S.A 83:246–250
    [Google Scholar]
  3. BANGHAM C. R. M., ASKONAS B. A. 1986; Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus. Journal of General Virology 67:623–629
    [Google Scholar]
  4. BANGHAM C. R. M., McMLCHAEL A. J. 1986; Specific human cytotoxic T cells recognize B cell lines persistently infected with respiratory syncytial virus. Proceedings of the National Academy of Sciences, U.S.A 83:9183–9187
    [Google Scholar]
  5. BANGHAM C. R. M., CANNON M. J., KARZON D. T., ASKONAS B. A. 1985; Cytotoxic T-cell response to respiratory syncytial virus in mice. Journal of Virology 56:55–59
    [Google Scholar]
  6. BANGHAM C. R. M., OPENSHAW P. J. M., BALL L. A., KING A. M. Q., WERTZ G. W., ASKONAS B. A. 1986; Human and murine cytotoxic T cells specific to respiratory syncytial virus recognise the viral nucleoprotein (N), but not the major glycoprotein (G) expressed by vaccinia virus recombinants. Journal of Immunology 137:3973–3977
    [Google Scholar]
  7. CANNON M. J. 1987; Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice. Journal of Virological Methods 16:293–301
    [Google Scholar]
  8. CANNON M. J., STOTT E. J., TAYLOR G., ASKONAS B. A. 1987; Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62:133–138
    [Google Scholar]
  9. CHANOCK R. M., KAPIKIAN A. Z., MILLS J., KIM H. W., PARROTT R. H. 1970; Influence of immunological factors in respiratory syncytial virus disease. Archives of Environmental Health 21:347–356
    [Google Scholar]
  10. COBBOLD S. P., JAYASURIYA A., NASH A., PROSPERO T. D., WALDMANN N. 1984; Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature, London 312:548
    [Google Scholar]
  11. ELANGO N., PRINCE G. A., MURPHY B. R., VENKATESAN R. M., CHANOCK R. M., MOSS B. 1986; Resistance to human respiratory syncytial virus infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of Sciences, U.S.A 83:1906
    [Google Scholar]
  12. FISHAUT M., TUBERGEN D., McINTOSH K. 1980; Cellular response to respiratory viruses with particular reference to children with disorders of cell mediated immunity. Journal of Pediatrics 96:179–186
    [Google Scholar]
  13. FULGINITI V. A., ELLER J. J., SIEBER O. F., JOYNER J. W., MINAMITANI M., MEIKLEJOHN G. 1969; Respiratory virus immunisation. I. A field trial of two inactivated respiratory virus vaccines: an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. American Journal of Epidemiology 89:435–448
    [Google Scholar]
  14. GARDNER P. S. 1973; Respiratory syncytial virus infections. Postgraduate Medical Journal 49:788–791
    [Google Scholar]
  15. GILLIS S., SMITH K. A. 1977; Long term culture of tumor-specific cytotoxic T cells dependent on IL-2. Nature, London 268:154–156
    [Google Scholar]
  16. GOTTLIEB P. D., MARSHAK-ROTHSTEIN A., AUDITORE-HARGRAVES K., BERKOBEN D. B., AUGUST D. A., ROSCHE R. M., BENEDETTO J. D. 1980; Construction and properties of new Lyt-congenic strains and anti-Lyt 2.2 andanti-Lyt 3.1 monoclonal antibodies. Immunogenetics 10:545
    [Google Scholar]
  17. GRUBER C., LEVINE S. 1985; Respiratory syncytial virus polypeptides. IV. The oligosaccharides of the glycoproteins. Journal of General Virology 66:417–432
    [Google Scholar]
  18. HALL C. B., POWELL K. R., MacDONALD N. E., GALA C. L., MENEGUS M. E., SUFFIN S. C., COHEN H. J. 1986; Respiratory syncytial viral infection in children with compromised immune function. New England Journal of Medicine 315:77–81
    [Google Scholar]
  19. HENDRICKS D. A., BARADARAN K., McINTOSH K., PATTERSON J. L. 1987; Appearance of a soluble form of the G protein of respiratory syncytial virus in the fluids of infected cells. Journal of General Virology 68:1705–1714
    [Google Scholar]
  20. KIM H. W., CANCHOLA J. G., BRANDT C. D., PYLES G., CHANOCK R. M., JENSEN K., PARROTT R. H. 1969; Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89:422–434
    [Google Scholar]
  21. KIM H. W., ARROBIO J. O., BRANDT C. D., JEFFERIES B. C, PYLES G., REID I. L., CHANOCK R. M., PARROTT R. H. 1973; Epidemiology of respiratory syncytial virus infection in Washington D.C. I. importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. American Journal of Epidemiology 98:216–225
    [Google Scholar]
  22. KIM H. W., LEIKIN S. L., ARROBIO J. O., BRANDT C. D., CHANOCK R. M., PARROTT R. H. 1980; Cell mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatric Research 10:75–78
    [Google Scholar]
  23. McINTOSH K. 1976; Bronchiolitis and asthma: possible common pathogenic mechanisms. Journal of Allergy and Clinical Immunology 57:595–604
    [Google Scholar]
  24. MOSMANN T. R., CHERWINSKI H., BOND M. W., GIEDLIN M. A., COFFMAN R. L. 1986; Two types of murine helper T cell clone. Journal of Immunology 136:2348–2357
    [Google Scholar]
  25. MUFSON M. A., ÖRVELL C, RAFNAR B., NORRBY E. 1985; Two distinct subtypes of human respiratory syncytial virus. Journal of General Virology 66:2111–2124
    [Google Scholar]
  26. OLMSTED R. A., ELANGO N., PRINCE G. A., MURPHY B. R., JOHNSON P. R., MOSS B., CHANOCK R. M., COLLINS P. L. 1986; Expression of the F glycoprotein in respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences, U.S.A 83:7462–7466
    [Google Scholar]
  27. PARROTT R. H., KIM W. H., ARROBIO J. O., HODES D. S., MURPHY B. R., BRANDT C. D., CAMARGO E., CHANOCK R. M. 1973; Epidemiology of respiratory syncytial virus infection in Washington D.C. II. Infection and disease with respect to age, immunologic status, race and sex. American Journal of Epidemiology 98:289–300
    [Google Scholar]
  28. PEMBERTON R. M., CANNON M. J., OPENSHAW P. J. M., BALL L. A., WERTZ G. W., ASKONAS B. A. 1987; Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. Journal of General Virology 68:2177–2182
    [Google Scholar]
  29. PRINCE G. A., HORSWOOD R. L., CAMARGO E., KOENIG D., CHANOCK R. M. 1983; Mechanisms of immunity to respiratory syncytial virus in cotton rats. Infection and Immunity 42:81–87
    [Google Scholar]
  30. PRINCE G. A., HORSWOOD R. L., CHANOCK R. M. 1985; Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. Journal of Virology 55:517–520
    [Google Scholar]
  31. SCHERLE P. A., GERHARD W. 1986; Function analysis of influenza-specific helper T cell clones in vivo: T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. Journal of Experimental Medicine 164:1114–1128
    [Google Scholar]
  32. STOTT E. J., BALL L. A., YOUNG K. K., FURZE J., WERTZ G. W. 1986; Human respiratory syncytial virus glycoprotein G expressed from recombinant vaccinia virus vector protects mice against live virus challenge. Journal of Virology 60:607–613
    [Google Scholar]
  33. TAYLOR G., STOTT E. J., BEW M., FERNIE B. F., COTE P. J., COLLINS A. P., HUGHES M., JEBBETT T. 1984; Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137–142
    [Google Scholar]
  34. WAGNER D. K., BARNEY S. G., WRIGHT P. F., WALSH E. E., KIM H. W., REIMER C. B., NELSON D. L., CHANOCK R. M., MURPHY B. R. 1986; Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. Journal of Clinical Microbiology 24:304–306
    [Google Scholar]
  35. WARD K. A., LAMBDEN P. R., OGLLVIE M. M., WATT P. J. 1983; Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. Journal of General Virology 64:1867–1876
    [Google Scholar]
  36. WEBB M. S. C, HENRY R. L., MILNER A. D., STOKES G. M., SWARBRICK A. S. 1985; Continuing problems three and a half years after acute viral bronchiolitis. Archives of Disease in Childhood 60:1064–1067
    [Google Scholar]
  37. WELLIVER R. C, KAUL T. N., SUN M., OGRA P. L. 1984; Defective regulation of immune responses in respiratory syncytial virus infection. Journal of Immunology 133:1925–1930
    [Google Scholar]
  38. WERTZ G. W., COLLINS P. L., HUANG Y., GRUBER C, LEVINE S., BALL L. A. 1985; Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proceedings of the National Academy of Sciences, U.S.A 82:4075–4079
    [Google Scholar]
  39. WERTZ G. W., STOTT E. J., YOUNG K. K. J., ANDERSON K., BALL L. A. 1987; Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. Journal of Virology 61:293–301
    [Google Scholar]
  40. WRIGHT P. F., BELSHE R. B., KIM L. P., VAN VORK L. P., CHANOCK R. M. 1982; Administration of a highly attenuated live respiratory syncytial virus vaccine to adults and children. Infection and Immunity 37:397–400
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-2-305
Loading
/content/journal/jgv/10.1099/0022-1317-69-2-305
Loading

Data & Media loading...

Most cited Most Cited RSS feed